51
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Causal Association Between Diabetes, Body Mass Index and Lichen Sclerosus: A Bidirectional Two-Sample Mendelian Randomization Analysis

, , & ORCID Icon
Pages 931-940 | Received 01 Dec 2023, Accepted 31 Mar 2024, Published online: 26 Apr 2024

References

  • Tran DA, Tan X, Macri CJ, Goldstein AT, Fu SW. Lichen Sclerosus: an autoimmunopathogenic and genomic enigma with emerging genetic and immune targets. Int J Biol Sci. 2019;15(7):1429–1439. doi:10.7150/ijbs.34613
  • De Luca DA, Papara C, Vorobyev A, et al. Lichen sclerosus: the 2023 update. Front Med. 2023;10:1106318.
  • Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc. 1971;57(1):9–30.
  • Kirtschig G, Cooper S, Aberer W, et al. Evidence-based (S3) guideline on (anogenital) lichen sclerosus. J Eur Acad Dermatol Venereol. 2017;31(2):e81–e83. doi:10.1111/jdv.13740
  • Halonen P, Jakobsson M, Heikinheimo O, Riska A, Gissler M, Pukkala E. Lichen sclerosus and risk of cancer. Int J Cancer. 2017;140(9):1998–2002. doi:10.1002/ijc.30621
  • Micheletti L, Preti M, Radici G, et al. Vulvar lichen sclerosus and neoplastic transformation: a retrospective study of 976 cases. J Low Genit Tract Dis. 2016;20(2):180–183. doi:10.1097/LGT.0000000000000186
  • Arif T, Fatima R, Sami M. Extragenital lichen sclerosus: a comprehensive review. Australas J Dermatol. 2022;63(4):452–462. doi:10.1111/ajd.13890
  • Virgili A, Borghi A, Cazzaniga S, et al. New insights into potential risk factors and associations in genital lichen sclerosus: data from a multicentre Italian study on 729 consecutive cases. J Eur Acad Dermatol Venereol. 2017;31(4):699–704. doi:10.1111/jdv.13867
  • Erickson BA, Elliott SP, Myers JB, et al. Understanding the relationship between chronic systemic disease and lichen sclerosus urethral strictures. J Urol. 2016;195(2):363–368. doi:10.1016/j.juro.2015.08.096
  • Hofer MD, Meeks JJ, Mehdiratta N, Granieri MA, Cashy J, Gonzalez CM. Lichen sclerosus in men is associated with elevated body mass index, diabetes mellitus, coronary artery disease and smoking. World J Urol. 2014;32(1):105–108. doi:10.1007/s00345-013-1090-7
  • Fekete GL, Schwarzkopf-Kolb D, Brihan I, Boda D, Fekete L. Balanitis xerotica obliterans: an observational, descriptive and retrospective clinical study. Exp Ther Med. 2022;23(5):361. doi:10.3892/etm.2022.11288
  • Magro CM, Kalomeris TA, Mo JH, Rice M, Nuovo G. Lichen sclerosus: a C5B-9 mediated chronic microvascular injury syndrome potentially reflective of common adult comorbidities. Ann Diagn Pathol. 2023;63:152098. doi:10.1016/j.anndiagpath.2022.152098
  • Ranum A, Freese R, Ramesh V, Pearson DR. Lichen sclerosus in female patients is associated with an increased risk of metabolic syndrome and cardiovascular comorbidities: a retrospective cohort review. Br J Dermatol. 2022;187(6):1030–1032. doi:10.1111/bjd.21811
  • Luu Y, Cheng AL, Reisz C. Elevated body mass index, statin use, and cholecystectomy are associated with vulvar lichen sclerosus: a retrospective, case-control study. J Am Acad Dermatol. 2023;88(6):1376–1378. doi:10.1016/j.jaad.2023.01.023
  • Sideri M, Parazzini F, Rognoni MT, et al. Risk factors for vulvar lichen sclerosus. Am J Obstet Gynecol. 1989;161(1):38–42. doi:10.1016/0002-9378(89)90228-7
  • Sekula P, Del Greco MF, Pattaro C, Köttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27(11):3253–3265. doi:10.1681/ASN.2016010098
  • Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–1163. doi:10.1002/sim.3034
  • Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195–R208. doi:10.1093/hmg/ddy163
  • Boef AG, Dekkers OM, le Cessie S. Mendelian randomization studies: a review of the approaches used and the quality of reporting. Int J Epidemiol. 2015;44(2):496–511. doi:10.1093/ije/dyv071
  • Xue A, Wu Y, Zhu Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9(1):2941. doi:10.1038/s41467-018-04951-w
  • Forgetta V, Manousaki D, Istomine R, et al. Rare genetic variants of large effect influence risk of type 1 diabetes. Diabetes. 2020;69(4):784–795. doi:10.2337/db19-0831
  • Yengo L, Sidorenko J, Kemper KE, et al. Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry. Hum Mol Genet. 2018;27(20):3641–3649. doi:10.1093/hmg/ddy271
  • Kurki MI, Karjalainen J, Palta P, et al. Author correction: finngen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;615(7952):E19.
  • Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7. 10.7554/eLife.34408
  • Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology. 2017;28(1):30–42. doi:10.1097/EDE.0000000000000559
  • Slob EAW, Groenen PJF, Thurik AR, Rietveld CA. A note on the use of egger regression in Mendelian randomization studies. Int J Epidemiol. 2017;46(6):2094–2097. doi:10.1093/ije/dyx191
  • Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–314. doi:10.1002/gepi.21965
  • Bowden J, Spiller W, Del Greco MF, et al. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the radial plot and radial regression. Int J Epidemiol. 2018;47(6):2100. doi:10.1093/ije/dyy265
  • Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–525. doi:10.1093/ije/dyv080
  • Gronau QF, Wagenmakers EJ. Limitations of bayesian leave-one-out cross-validation for model selection. Comput Brain Behav. 2019;2(1):1–11. doi:10.1007/s42113-018-0011-7
  • Taylor AH, Guzail M, Al-Azzawi F. Differential expression of oestrogen receptor isoforms and androgen receptor in the normal vulva and vagina compared with vulval lichen sclerosus and chronic vaginitis. Br J Dermatol. 2008;158(2):319–328. doi:10.1111/j.1365-2133.2007.08371.x
  • Sherman V, McPherson T, Baldo M, Salim A, Gao XH, Wojnarowska F. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol. 2010;24(9):1031–1034. doi:10.1111/j.1468-3083.2010.03572.x
  • Azurdia RM, Luzzi GA, Byren I, et al. Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease. Br J Dermatol. 1999;140(1):79–83. doi:10.1046/j.1365-2133.1999.02611.x
  • Marren P, Yell J, Charnock FM, Bunce M, Welsh K, Wojnarowska F. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol. 1995;132(2):197–203. doi:10.1111/j.1365-2133.1995.tb05013.x
  • Powell J, Wojnarowska F, Winsey S, Marren P, Welsh K. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol. 2000;142(3):481–484. doi:10.1046/j.1365-2133.2000.03360.x
  • García-Bravo B, Sánchez-Pedreño P, Rodríguez-Pichardo A, Camacho F. Lichen sclerosus et atrophicus. A study of 76 cases and their relation to diabetes. J Am Acad Dermatol. 1988;19(3):482–485. doi:10.1016/S0190-9622(88)70201-7
  • Edmonds E, Barton G, Buisson S, et al. Gene expression profiling in male genital lichen sclerosus. Int J Exp Pathol. 2011;92(5):320–325. doi:10.1111/j.1365-2613.2011.00779.x
  • Kirtschi G. Lichen sclerosus-presentation diagnosis and management. Dtsch Arztebl Int. 2016;113(19):337–343. doi:10.3238/arztebl.2016.0337
  • de Lusignan S, Alexander H, Broderick C, et al. Atopic dermatitis and risk of autoimmune conditions: population-based cohort study. J Allergy Clin Immunol. 2022;150(3):709–713. doi:10.1016/j.jaci.2022.03.030
  • Xu X, Zhang H, Li L, et al. Study of the involvement of the P2Y12 receptor in chronic itching in type 2 diabetes mellitus. Mol Neurobiol. 2022;59(3):1604–1618. doi:10.1007/s12035-021-02676-4
  • Roh YS, Choi J, Sutaria N, Kwatra SG. Itch: epidemiology, clinical presentation, and diagnostic workup. J Am Acad Dermatol. 2022;86(1):1–14. doi:10.1016/j.jaad.2021.07.076
  • Stawiski MA, Voorhees JJ. Cutaneous signs of diabetes mellitus. Cutis. 1976;18(3):415–421.